Navigation Links
Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Date:1/17/2008

LA JOLLA, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) announced today that the first phase of a formal "Proof of Concept Trial" for the biopharmaceutical SF-1019 has been successfully completed in Europe for treatment of Diabetic Ulcers.

The Board of Immunosyn was advised as to the success of this important phase of the "Proof of Concept Trial" by Argyll Biotechnologies, LLC its strategic partner and largest shareholder. Argyll Biotechnologies is the developer and licensor of SF-1019, for which Immunosyn has been granted the world-wide rights to market, sell and distribute under an exclusive license agreement.

The primary purpose of the "Proof of Concept Trial" is to further evaluate the safety and efficacy of SF-1019 in the treatment of Diabetic Ulceration and its effect on Diabetic Polyneuropathy in Type 1 Diabetes Mellitus by both subcutaneous injection and by topical application.

Regarding the "Proof of Concept Trial," Professor Angus Dalgleish, MBBS, BSc, MD, FRCP, RACP, FRCPath, FMedSci, Chief Scientist and Consultant Medical Officer for Argyll Biotechnologies, LLC stated that, "This first very important phase in the development of SF-1019, which was undertaken at a European venue, has indicated that SF-1019 promotes wound healing and almost certainly induces growth factors." "When systemically delivered, SF-1019 has shown the rapid resolution of long standing chronic lesions which is very impressive. And the topical application of SF-1019, while showing promise, in that a 5mm deep wound became closed, needs, as expected, unlike the subcutaneous method, more short-term development in order to improve the delivery methodology," he added.

Clinical Director for Argyll Biotechnologies, David Maizels, MD, MSc, MRCS, LRCP, has also advised that, "Because of the positive results, which both the independent clinical team and I have observed during the first phase of the "Proof of Concept
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... that most 18-month-olds learn an average of two to ... about how children process information to learn new words ... new study, a University of Missouri researcher has found ... a limit exists as to how many words they ... enhance their children,s vocabularies and assist speech-language professionals in ...
(Date:9/17/2014)... In a country where 77% of inhabitants ... basis, how can Americans find healthy and fulfilling ways ... Challenge , a 5-day interactive journey to putting stress ... From September 29th – October 3rd, the Hyland’s Stress ... specific topics that promote natural solutions for managing stress. ...
(Date:9/17/2014)... By Kathleen Doheny ... -- Sixteen major food and beverage companies have made good ... a new report finds. The companies, acting together through ... calories from the market between 2007 and 2012 and 1.5 ... calories. "The 16 companies collectively met their pledge and ...
(Date:9/17/2014)... 2014 People with bipolar disorder who do yoga believe ... survey study in the September Journal of Psychiatric ... Lippincott Williams & Wilkins , a part of Wolters ... believe that yoga has had a significant positive impact on ... Uebelacker of Butler Hospital and Brown University, Providence, R.I., and ...
(Date:9/17/2014)... September 17, 2014 For over a ... of MadgeTech data logging products to industries in Greece ... and the development of management systems for certification and ... quality, and technical support. , MadgeTech Inc. is ... internationally. “We are very pleased to see the success ...
Breaking Medicine News(10 mins):Health News:Babies learn words differently as they age, researcher finds 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3Health News:Yoga may help people with bipolar disorder, reports Journal of Psychiatric Practice 2Health News:Yoga may help people with bipolar disorder, reports Journal of Psychiatric Practice 3Health News:Main Solutions Now Distributing MadgeTech Data Loggers in Bulgaria 2
... 2012 Updated guidelines on nutrition and physical activity ... stress the importance of creating social and physical ... updated recommendations for individual choices regarding diet and ... occur within a community context that can either ...
... Mary, University of London suggests that omega-3 fatty acids, which ... nerves from injury and help them to regenerate. When ... experience pain, weakness and muscle paralysis which can leave them ... published this week in the Journal of Neuroscience *, ...
... HealthDay Reporter , TUESDAY, Jan. 10 (HealthDay News) -- ... to trigger declines in lung function that could lead to ... you down that road toward breathlessness, but low to moderate ... But there were limits to the study. For example, ...
... TUESDAY, Jan. 10 (HealthDay News) -- Children with autism have ... seen in kids who do not have the disorder, researchers ... in the online journal mBio , researchers from the ... York City suggested that this finding could help explain the ...
... , TUESDAY, Jan. 10 (HealthDay News) -- People with dementia ... who don,t have any impairment in their brain function, a ... the hospitalizations that occur in people with dementia are for ... study shows. "Hospital admissions for all causes and ...
... Jan. 10 (HealthDay News) -- Heart attack patients whose blood ... to die than those with levels of the mineral below ... current recommendations for potassium levels in heart attack patients. ... admitted to 67 U.S. hospitals between 2000 and 2008. Of ...
Cached Medicine News:Health News:Updated American Cancer Society nutrition guidelines stress need for supportive environment 2Health News:Updated American Cancer Society nutrition guidelines stress need for supportive environment 3Health News:Omega-3 fatty acids could prevent and treat nerve damage, research suggests 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 3Health News:Autism Gastro Problems May Be Linked to Gut Bacteria 2Health News:Dementia May Lead to Avoidable Hospitalizations 2Health News:Dementia May Lead to Avoidable Hospitalizations 3Health News:Study Challenges Potassium Guidelines for Heart Attack Patients 2
(Date:9/17/2014)... Mass. , Sept. 17, 2014 /PRNewswire/ ... disease/ulcerative colitis (CD/UC) patients eligible for biologic ... receive a biologic. Surveyed gastroenterologists cite patients, ... reason for low penetration rates, followed by ... and UC patients receiving biologics, Janssen Biotech,s ...
(Date:9/17/2014)... MARINA DEL REY, Calif. , Sept. 17, ... launch of the Prostate Vanguard, an awareness campaign to ... replace multiple rectal needle biopsies of the prostate. ... of the prostate gland through the rectum. Multi-parametric MRI ... for diagnosing clinically-significant prostate cancer (CSPC). Men need ...
(Date:9/17/2014)... 2014 Bronstein, Gewirtz & Grossman, LLC is ... securities of PDL BioPharma, Inc. ("PDL BioPharma" or the ... are advised to contact Peretz Bronstein or ... info@bgandg.com or 212-697-6484. The investigation ... executives violated federal securities laws. On September ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
... part of the eighth annual DVT (deep-vein thrombosis) Awareness Month, ... of DVT and its risk factors among patients with co-morbid ... respiratory and obesity patients.   DVT remains the ... deaths may be due to PE (pulmonary embolism).(1)  This is ...
... Ill., March 9, 2011 Hospira, Inc. (NYSE: ... announced U.S. Food and Drug Administration (FDA) approval of docetaxel. ... Hospira expects to launch the product later this month. ... variety of cancers. In 2010, U.S. sales of Taxotere were ...
Cached Medicine Technology:Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 2Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 3Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 4Hospira Announces U.S. Approval of Generic Docetaxel 2
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... The Guidant Flextend lead ... pace/sense lead with an ... extendable/retractable helix design offers ... for permanent implantation in ...
... The PY series leads are ... leads for stimulation of either the ... active fixation screw can be extended ... pin. The lead tip contains an ...
Used with permanent pacing leads....
Medicine Products: